Die chronische Nierenerkrankung (CKD) ist durch einen progressiven, schleichenden Verlauf gekennzeichnet, was ein aktives Monitoring sehr wichtig macht.
The diagnosis moment: – the role of POCT HbA1c in undiagnosed diabetes and prediabetes in plowing the progression of diabetes and improving health equ...
Chronic disease management in the post COVID era - the value of point of care testing for cardiovascular risk and kidney disease management in diabete...
Health Information and Quality Authority (HIQA), online veröffentlicht im April 2019
Ziel dieser Gesundheitstechnologiebewertung (HTA) war es, die klinische und Kostenwirksamkeit des CRP-POCTs zu ermitteln und die organisatorischen Auswirkungen einer möglichen Einführung der Technologie in der Primärversorgung zu untersuchen. Nachstehend finden Sie eine Zusammenfassung der wichtigsten Ergebnisse:
Die antimikrobielle Resiste...
Health Technology Assessment (HTA) von CRP-POCTs als Orientierungshilfe für die Verschreibung von Antibiotika in der Primärversorgung von akuten Atemw...
Jan Verbakel, Joseph Lee, Clare Goyder, Pui San Tan, Thanusha Ananthakumar, Philip Turner, Gail Hayward und Ann Van den Bruel
BMJ Open, 2019
Ziel dieser Überprüfung war es, alle verfügbaren Nachweise über die Auswirkungen des Point-of-Care-Tests (POCT) für C-reaktives Protein (CRP) auf patientenrelevante Ergebnisse bei Kindern und Erwachsenen in der ambulanten Versorgung zusammenzutragen. Insgesamt wurden 11 randomisierte kontrolli...
Auswirkung von CRP POC-Tests in der ambulaten Versorgung: eine systematische Auswertung und Metaanalyse
Erna Lenters-Westra, und Emma English
Journal of Diabetes Science and Technology 2018;12(4):762-770
Angesichts der Bedeutung von Point-of-Care-Tests (POCT) in der Gesundheitsversorgung untersuchen Lenters-Westra und English die Qualitätskriterien, die zur Bewertung von POCT-Geräten herangezogen werden, um festzustellen, ob diese denselben Standard wie die wichtigsten Laboranalysegeräte erfüllen. Sie wenden die Protokolle EP-5 und EP...
Bewertung von vier HbA1c-POC-Geräten anhand internationaler Qualitätsziele: Sind sie für den Zweck geeignet?
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1.
Impact of ACR POC testing on the diagnosis and management of diabetic kidney disease
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1.
Should you screen for kidney damage? What do the guidelines say?
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1.
Gain the latest insights on respiratory infections and related rapid tests aimed at expediting appropriate isolation decisions and antiviral treatments. Be informed on the technology differences in diagnostic test methods and hear use cases on testing protocols focused on efficient patient management and quality initiatives, including antimicrobial stewardship.
Respiratory Season: New Diagnostic Challenges and Strategies for Antimicrobial Stewardship
This webinar will discuss screening for and prevention of chronic disease in severe mental illness (SMI) patients and patients with learning disabilities (LD).
The value of POCT in SMI health checks and patients with learning disabilities for the diagnosis, management and monitoring of diabetes and cardiovasc...
In this new webinar session, Doctor Nguyen explores the impact of the implementation of rapid molecular biology tests in the emergency department and the impact on patients care management within the emergency room.
Clinical and operational impact of rapid point-of-care SARS-COV-2 detection in an emergency department
Albuminuria, commonly measured as urine albumin-to-creatinine ratio (ACR), is an under-recognized component of chronic kidney disease (CKD) definition, staging and prognosis.
Albuminuria, elevated serum creatinine and low estimated glomerular filtration rate (eGFR) are key indicators of kidney decline. However, it is unclear if these biomarkers are independent predictors of kidney disease progression in people with type 2 diabetes mellitus (T2DM).
ACR and eGFR as predictors of cardio-renal outcomes in diabetes and kidney disease
